List of Studies ( Metabolite:Inositol cyclic phosphate)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004334 | AN007238 | Oxidative pentose phosphate pathway is required for T cell activation and anti-tumor immunity - PGD-knockout | T-cells | Mouse | Cancer | Princeton University | LC-MS |
| ST004333 | AN007236 | Oxidative pentose phosphate pathway is required for T cell activation and anti-tumor immunity - G6PD-knockout | T-cells | Mouse | Cancer | Princeton University | LC-MS |
| ST004200 | AN006985 | untargeted metabolomics in serum of microplastics exposed mice - Untargeted LC/MS | Blood | Mouse | Environmental exposure | University of Washington | LC-MS |
| ST004200 | AN006986 | untargeted metabolomics in serum of microplastics exposed mice - Untargeted LC/MS | Blood | Mouse | Environmental exposure | University of Washington | LC-MS |
| ST004194 | AN006967 | PfK13-associated artemisinin resistance slows drug activation and enhances antioxidant defence, which can be overcome with sulforaphane | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003790 | AN006230 | Fecal metabolomics of B16-OVA tumor-bearing mice fed chow or low and high fiber purified diets and treated with isotype control or anti-PD-1 antibody | Feces | Mouse | Cancer | Princeton University | LC-MS |
| ST003789 | AN006228 | Serum metabolomics of B16-OVA tumor-bearing mice fed chow or low and high fiber purified diets and treated with isotype control or anti-PD-1 antibody | Blood | Mouse | Cancer | Princeton University | LC-MS |
| ST003778 | AN006206 | Human to mouse microbiota transfer model demonstrates disease-modifying effects of the short-chain fatty acid biotherapy modified microbiota | Feces | Mouse | Diabetes | University of Queensland | LC-MS |
| ST003655 | AN006005 | Bacteria-derived 3-hydroxydodecanoic acid induces a potent anti-tumor immune response via GPR84 receptor | Blood | Human | Cancer | Universitätsspital Zürich | MALDI-MS |
| ST003655 | AN006005 | Bacteria-derived 3-hydroxydodecanoic acid induces a potent anti-tumor immune response via GPR84 receptor | Blood | Mouse | Cancer | Universitätsspital Zürich | MALDI-MS |
| ST003565 | AN005858 | Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003483 | AN005720 | Tissue niche influences immune and metabolic profiles to Staphylococcus aureus biofilm infection (Extracellular data) | Brain | Mouse | Bacterial infection | University of Nebraska Medical Center | LC-MS |
| ST003483 | AN005720 | Tissue niche influences immune and metabolic profiles to Staphylococcus aureus biofilm infection (Extracellular data) | Galea | Mouse | Bacterial infection | University of Nebraska Medical Center | LC-MS |
| ST003483 | AN005720 | Tissue niche influences immune and metabolic profiles to Staphylococcus aureus biofilm infection (Extracellular data) | PJI Tissue | Mouse | Bacterial infection | University of Nebraska Medical Center | LC-MS |
| ST003179 | AN005222 | Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003160 | AN005185 | New class of heterospirocyclic compounds present strong and rapid activity against artemisinin- and multidrug-resistant P. falciparum parasites | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003144 | AN005159 | On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003126 | AN005125 | Effect of high fat diet on heart metabolome of CHCHD10 mutant mice | Heart | Mouse | Cardiomyopathy | Weill Cornell Medicine | LC-MS |
| ST002926 | AN004799 | Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002792 | AN004542 | Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002776 | AN004519 | Zebrafish Optic Nerve Regeneration, Tectum Metabolomics - 3 Days Post Crush | Eye tissue | Zebrafish | Eye disease | University of Miami | LC-MS |
| ST002776 | AN004520 | Zebrafish Optic Nerve Regeneration, Tectum Metabolomics - 3 Days Post Crush | Eye tissue | Zebrafish | Eye disease | University of Miami | LC-MS |
| ST002775 | AN004517 | Zebrafish Retina Regeneration Metabolomics - 3 Days Post Crush | Eye tissue | Zebrafish | Eye disease | University of Miami | LC-MS |
| ST002775 | AN004518 | Zebrafish Retina Regeneration Metabolomics - 3 Days Post Crush | Eye tissue | Zebrafish | Eye disease | University of Miami | LC-MS |
| ST002551 | AN004200 | Metabolomics dataset of CNTF induced axon regeneration in mice post optic nerve crush | Eye tissue | Mouse | Eye disease | University of Miami | LC-MS |
| ST002551 | AN004201 | Metabolomics dataset of CNTF induced axon regeneration in mice post optic nerve crush | Eye tissue | Mouse | Eye disease | University of Miami | LC-MS |
| ST002444 | AN003981 | Zebrafish Optic Nerve Regeneration Metabolomics - 3 Days Post Crush | Eye tissue | Zebrafish | Eye disease | University of Miami | LC-MS |
| ST002444 | AN003982 | Zebrafish Optic Nerve Regeneration Metabolomics - 3 Days Post Crush | Eye tissue | Zebrafish | Eye disease | University of Miami | LC-MS |
| ST002412 | AN003931 | Metabolic effects of the protein kinase R | Macrophages | Mouse | Hudson Institute of Medical Research | LC-MS | |
| ST002412 | AN003932 | Metabolic effects of the protein kinase R | Macrophages | Mouse | Hudson Institute of Medical Research | LC-MS | |
| ST002309 | AN003772 | Targeting malaria parasites with novel derivatives of azithromycin | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002111 | AN003455 | Metabolomics dataset of optogenetic axon regenerative mouse model post optic nerve crush | Eye tissue | Mouse | Eye disease | University of Miami | LC-MS |
| ST002108 | AN003448 | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002108 | AN003449 | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002107 | AN003447 | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002066 | AN003365 | Glutaminase inhibition impairs CD8 T cell activation in STK11/Lkb1 deficient lung cancer | Lung | Mouse | Cancer | Walter and Eliza Hall Institute of Medical Research | LC-MS |
| ST001788 | AN002900 | β-Adrenergic regulation of metabolism in macrophages (part-IV) | Macrophages | Human | Monash University | LC-MS | |
| ST001680 | AN002739 | Metabolome of NAFLD in high fat diet mouse model | Liver | Mouse | Fatty liver disease | Weill Cornell Medicine | LC-MS |
| ST001549 | AN002580 | β-Adrenergic regulation of metabolism in macrophages (part-III) | Macrophages | Human | Monash University | LC-MS | |
| ST001549 | AN002581 | β-Adrenergic regulation of metabolism in macrophages (part-III) | Macrophages | Human | Monash University | LC-MS | |
| ST001547 | AN002576 | β-Adrenergic regulation of metabolism in macrophages | Macrophages | Human | Monash University | LC-MS | |
| ST001315 | AN002190 | Retargeting azithromycin-like compounds as antimalarials with dual modality | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001304 | AN002172 | Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii | Fibroblast cells | Toxoplasma gondii | Parasitic infection | Monash University | LC-MS |
| ST001276 | AN002117 | Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001274 | AN002115 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001205 | AN002006 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
| ST001205 | AN002006 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001204 | AN002005 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
| ST001204 | AN002005 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001202 | AN002000 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
| ST001202 | AN002000 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001201 | AN001999 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
| ST001201 | AN001999 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001175 | AN001950 | Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001033 | AN001694 | Determination of mode of action of anti-malalrial drugs using untargeted metabolomics | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST000539 | AN000818 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) | Cells | Human | Monash University | LC-MS | |
| ST000414 | AN000655 | Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action | Cells | Plasmodium falciparum | Malaria | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST000414 | AN000656 | Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action | Cells | Plasmodium falciparum | Malaria | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST000403 | AN000642 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes | Cells | Human | Monash Institute of Pharmaceutical Sciences | LC-MS | |
| ST000248 | AN000392 | Metabolic heterogeneity in Glioblastoma | Glioma cells | Human | Cancer | University of Florida | LC-MS |
| ST000230 | AN000343 | Comprehensive analysis of transcriptome and metabolome in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma | Liver | Human | Cancer | Osaka City University | LC-MS |
| ST000040 | AN000060 | Heatshock response of C. elegans using IROA (I) | Worms | C. elegans | University of Florida | LC-MS | |
| ST000040 | AN000061 | Heatshock response of C. elegans using IROA (I) | Worms | C. elegans | University of Florida | LC-MS |
